Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: COVID-19-News  Dec 09, 2020  3 years, 4 months, 1 week, 1 day, 15 hours, 47 minutes ago

COVID-19-News: Scientist From Rutgers University Warns That Guillain–Barré Syndrome Can Be Triggered By SARS-CoV-2

COVID-19-News: Scientist From Rutgers University Warns That Guillain–Barré Syndrome Can Be Triggered By SARS-CoV-2
Source: COVID-19-News  Dec 09, 2020  3 years, 4 months, 1 week, 1 day, 15 hours, 47 minutes ago
COVID-19-News: Medical researchers from the  Rutgers Robert Wood Johnson Medical School-New Jersey have reported the first documented case of COVID-19 triggering a recurrence of Guillain-Barré Syndrome , a rare disorder where the body's immune system attacks nerves and can lead to respiratory failure and death.


 
COVID-19 has been reported to trigger Guillain–Barré syndrome (GBS). While uncommon, recurrent GBS (rGBS) episodes, triggered by antecedent viral infections, have been reported in a small proportion of GBS patients, here the study team describes a patient with a recurrent case of GBS, occurring secondary to COVID-19 infection. Before this patient’s episode, he had two prior GBS flares, each precipitated by a viral infection followed by complete recovery besides intermittent paresthesias. The study team also considered the nosology of this illness in the spectrum of rGBS and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), with their differing natural histories, prognosis, and therapeutic approaches. For patients who have a history of inflammatory demyelinating polyradiculopathies who develop COVID-19, the study team recommends close observation for neurologic symptoms over the next days and weeks. 
 
The case report was published in the peer reviewed journal: Pathogens https://www.mdpi.com/2076-0817/9/11/965
 
Thailand Medical News had already published warnings about the potential of COVID-19 to cause Guillain–Barré Syndrome as early as July. https://www.thailandmedical.news/news/breaking-guillain-barre-syndrome-a-rare-neurological-disorder-manifesting-in-more-covid-19-patients
 
Guillain- Barré syndrome is a rare disorder in which the body's immune system attacks the nerves. Weakness and tingling in the extremities are usually the first symptoms.
 
These sensations can quickly spread, eventually paralyzing the whole body. In its most severe form Guillain-Barre syndrome is a medical emergency. Most individuals with the condition must be hospitalized to receive treatment.
The symptoms of Guillain-Barre syndrome often begins with tingling and weakness starting in the feet and legs and spreading to the upper body and arms. In about 10% of individuals with the disorder, symptoms begin in the arms or face. As Guillain-Barre syndrome progresses, muscle weakness can evolve into paralysis.
 
Typical signs and symptoms of Guillain-Barre syndrome may include:
 
-Weakness in the legs that spreads to the upper body
 
-Unsteady walking or inability to walk or climb stairs
 
-Prickling, pins and needles sensations in the fingers, toes, ankles or wrists
 
-Difficulty with facial movements, including speaking, chewing or swallowing
Double vision or inability to move eyes
 
-Severe pain that may feel achy, shooting or cramplike and may be worse at night
 
-Rapid heart rate
 
-Low or high blood pressure
 
-Difficulty with bladder control or bowel function
 
-Difficulty breathing
 
Individuals with Guillain-Barre syndrome usually experience their most significant weakness within two weeks after symptoms begin.
 
Recent research has shown that COVID-19 has been associated with a broad range of immune neuropathies, including Guillain–Barré syndrome (GBS) and the worsening of Chronic Inflammatory Demyelinating Polyradiculopathy (CIDP). https://pubmed.ncbi.nlm.nih.gov/32781484/
 
https://pubmed.ncbi.nlm.nih.gov/32911389/
&nbs